We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood and Body Fluid Analyzer Developed for Medium-Sized Labs

By LabMedica International staff writers
Posted on 21 May 2009
A new, automatic analyzer has been developed for analysis of blood and body fluids in hospitals with medium-sized laboratories. More...
The analyzer will play an important part in the diagnosis of a number of diseases, including different types of infection and leukemia.

Automated digital cell morphology is the process by which cells are automatically located on a stained peripheral blood or body fluid smear, preclassified, stored, and presented for confirmation by a technologist. The images then become available for access by physicians at any time for perusal.

Using the new analyzer laboratories can achieve time reductions (up to 50 %) and more standardized analyses. To count and classify white blood cells is a very common routine analysis in hematology laboratories. Trends indicate that medium-sized laboratories would like to automate the analytical process. Increased automation gives lab personnel more time and increases objectivity, safety, and standardization in the analytical work.

Called CellaVision DM1200, the instrument is CellaVision's (Lund, Sweden) next generation analyzer, and is the latest addition to the company's current range of products that include CellaVision DM96 and CellaVision DM8. The new instrument is based on a new cost-reduced hardware platform, is automated, and has a wider range of uses. Body fluid software can be added to the analyzer for analysis of fluids such as cerebrospinal fluid.

The official product launch will take place at the international Annual Meeting & Clinical Lab Expo AACC in Chicago, USA, on July 20-24, 2009. CellaVision DM1200 will be commercially available in Europe in around the same time.

CellaVision AB develops and markets systems for automatic differentials of white blood cells and erythrocyte morphology, and software for education and quality assurance of differentials.

Related Links:

CellaVision



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Pipette
Accumax Smart Series
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.